BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Desai P, Rimal R, Sahnoun SEM, Mottaghy FM, Möller M, Morgenroth A, Singh S. Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers. Small. [DOI: 10.1002/smll.202200673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chakraborty K, Mondal J, An JM, Park J, Lee Y. Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics. Pharmaceutics 2023;15:971. [DOI: 10.3390/pharmaceutics15030971] [Reference Citation Analysis]
2 Ahmadi M, Khoramjouy M, Dadashzadeh S, Asadian E, Mosayebnia M, Geramifar P, Shahhosseini S, Ghorbani-bidkorpeh F. Pharmacokinetics and biodistribution studies of [99mTc]-Labeled ZIF-8 nanoparticles to pave the way for image-guided drug delivery and theranostics. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104249] [Reference Citation Analysis]
3 Chakravarty R, Sen N, Ghosh S, Sarma HD, Guleria A, Singh KK, Chakraborty S. Flow synthesis of intrinsically radiolabeled and renal-clearable ultrasmall [198Au]Au nanoparticles in a PTFE microchannel. Chemical Engineering Journal Advances 2023. [DOI: 10.1016/j.ceja.2023.100456] [Reference Citation Analysis]
4 He T, Ao J, Duan C, Yan R, Li X, Liu L, Zhang J, Li X. Bibliometric and visual analysis of nephrotoxicity research worldwide. Front Pharmacol 2022;13:940791. [DOI: 10.3389/fphar.2022.940791] [Reference Citation Analysis]
5 Xue A, Fan S. Matrices and Affinity Ligands for Antibody Purification and Corresponding Applications in Radiotherapy. Biomolecules 2022;12:821. [PMID: 35740946 DOI: 10.3390/biom12060821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]